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Differentiated cells can be reprogrammed to an
embryonic-like state by transfer of nuclear con-
tents into oocytes or by fusion with embryonic
stem (ES) cells. Little is known about factors
that induce this reprogramming. Here, we dem-
onstrate induction of pluripotent stem cells
from mouse embryonic or adult fibroblasts by
introducing four factors, Oct3/4, Sox2, c-Myc,
and Klf4, under ES cell culture conditions.
Unexpectedly, Nanog was dispensable. These
cells, which we designated iPS (induced plurip-
otent stem) cells, exhibit the morphology and
growth properties of ES cells and express ES
cell marker genes. Subcutaneous transplanta-
tion of iPS cells into nude mice resulted in
tumors containing a variety of tissues from all
three germ layers. Following injection into blas-
tocysts, iPS cells contributed to mouse embry-
onic development. These data demonstrate
that pluripotent stem cells can be directly gen-
erated from fibroblast cultures by the addition
of only a few defined factors.
INTRODUCTION
Embryonic stem (ES) cells, which are derived from the in-
ner cell mass of mammalian blastocysts, have the ability
to grow indefinitely while maintaining pluripotency and
the ability to differentiate into cells of all three germ layers
(Evans and Kaufman, 1981; Martin, 1981). Human ES cells
might be used to treat a host of diseases, such as Parkin-
son’s disease, spinal cord injury, and diabetes (Thomson
et al., 1998). However, there are ethical difficulties regard-
ing the use of human embryos, as well as the problem of
tissue rejection following transplantation in patients. One
way to circumvent these issues is the generation of plu-
ripotent cells directly from the patients’ own cells.
Somatic cells can be reprogrammed by transferring
their nuclear contents into oocytes (Wilmut et al., 1997)or by fusion with ES cells (Cowan et al., 2005; Tada
et al., 2001), indicating that unfertilized eggs and ES cells
contain factors that can confer totipotency or pluripotency
to somatic cells. We hypothesized that the factors that
play important roles in the maintenance of ES cell identity
also play pivotal roles in the induction of pluripotency in
somatic cells.
Several transcription factors, including Oct3/4 (Nichols
et al., 1998; Niwa et al., 2000), Sox2 (Avilion et al., 2003),
and Nanog (Chambers et al., 2003; Mitsui et al., 2003),
function in the maintenance of pluripotency in both early
embryos and ES cells. Several genes that are frequently
upregulated in tumors, such as Stat3 (Matsuda et al.,
1999; Niwa et al., 1998), E-Ras (Takahashi et al., 2003),
c-myc (Cartwright et al., 2005), Klf4 (Li et al., 2005), and
b-catenin (Kielman et al., 2002; Sato et al., 2004), have
been shown to contribute to the long-term maintenance
of the ES cell phenotype and the rapid proliferation of
ES cells in culture. In addition, we have identified several
other genes that are specifically expressed in ES cells
(Maruyama et al., 2005; Mitsui et al., 2003).
In this study, we examined whether these factors could
induce pluripotency in somatic cells. By combining four
selected factors, we were able to generate pluripotent
cells, which we call induced pluripotent stem (iPS) cells,
directly from mouse embryonic or adult fibroblast cul-
tures.
RESULTS
We selected 24 genes as candidates for factors that
induce pluripotency in somatic cells, based on our
hypothesis that such factors also play pivotal roles in the
maintenance of ES cell identity (see Table S1 in the
Supplemental Data available with this article online). For
b-catenin, c-Myc, and Stat3, we used active forms,
S33Y-b-catenin (Sadot et al., 2002), T58A-c-Myc (Chang
et al., 2000), and Stat3-C (Bromberg et al., 1999), respec-
tively. Because of the reported negative effect of Grb2
on pluripotency (Burdon et al., 1999; Cheng et al., 1998),
we included its dominant-negative mutant Grb2DSH2
(Miyamoto et al., 2004) as 1 of the 24 candidates.Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc. 663
Figure 1. Generation of iPS Cells from MEF Cultures via 24 Factors
(A) Strategy to test candidate factors.
(B) G418-resistant colonies were observed 16 days after transduction with a combination of 24 factors. Cells were stained with crystal violet.
(C) Morphology of ES cells, iPS cells (iPS-MEF24, clone 1-9), and MEFs. Scale bars = 200 mm.
(D) GrowthcurvesofEScells, iPScells (iPS-MEF24, clones2-1–4), andMEFs. 33105cellswerepassagedevery 3days into eachwell of six-well plates.
(E) RT-PCRanalysis of EScellmarker genes in iPScells (iPS-MEF24, clones1-5, 1-9, and1-18), EScells, andMEFs.Nat1wasusedasa loading control.
(F) Bisulfite genomic sequencing of the promoter regions ofOct3/4,Nanog, andFbx15 in iPS cells (iPS-MEF24, clones 1-5, 1-9, and 1-18), ES cells, and
MEFs. Open circles indicate unmethylated CpG dinucleotides, while closed circles indicate methylated CpGs.To evaluate these 24 candidate genes, we developed
an assay system in which the induction of the pluripotent
state could be detected as resistance to G418 (Figure 1A).
We inserted a bgeo cassette (a fusion of the b-galactosi-
dase and neomycin resistance genes) into the mouse
Fbx15 gene by homologous recombination (Tokuzawa
et al., 2003). Although specifically expressed in mouse
ES cells and early embryos, Fbx15 is dispensable for the
maintenance of pluripotency and mouse development.664 Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc.ES cells homozygous for the bgeo knockin construct
(Fbx15bgeo/bgeo) were resistant to extremely high concen-
trations of G418 (up to 12 mg/ml), whereas somatic cells
derived from Fbx15bgeo/bgeo mice were sensitive to a nor-
mal concentration of G418 (0.3 mg/ml). We expected that
even partial activation of the Fbx15 locus would result in
resistance to normal concentrations of G418.
We introduced each of the 24 candidate genes into
mouse embryonic fibroblasts (MEFs) from Fbx15bgeo/bgeo
Figure 2. Narrowing down the Candidate Factors
(A) Effect of the removal of individual factors from the pool of 24 transduced factors on the formation of G418-resistant colonies. Fbx15bgeo/bgeoMEFs
were transduced with the indicated factors and selected with G418 for 10 days (white columns) or 16 days (black columns).
(B) Effect of the removal of individual factors from the selected 10 factors on the formation of G418-resistant colonies 16 days after transduction.
(C) Effect of the transduction of pools of four, three, and two factors on the formation of G418-resistant colonies 16 days after transduction.
(D) Morphologies of iPS-MEF4 (clone 7), iPS-MEF10 (clone 6), and iPS-MEF3 (clone 3). Scale bars = 200 mm.embryos by retroviral transduction (Morita et al., 2000).
Transduced cells were then cultured on STO feeder cells
in ES cell medium containing G418 (0.3 mg/ml). We did
not, however, obtain drug-resistant colonies with any sin-
gle factor, indicating that no single candidate gene was
sufficient to activate the Fbx15 locus (Figure 1B; see
also Table S2, which summarizes all of the transduction
experiments in this study).
In contrast, transduction of all 24 candidates together
generated 22 G418-resistant colonies (Figure 1B). Of the
12 clones for which we continued cultivating under selec-
tion, 5 clones exhibited morphology similar to ES cells,
including a round shape, large nucleoli, and scant cyto-
plasm (Figure 1C). We repeated the experiments and ob-
served 29 G418-resistant colonies, from which we picked
6 colonies. Four of these clones possessed ES cell-like
morphology and proliferation properties (Figure 1D). The
doubling time of these cells (19.4, 17.5, 18.7, and 18.6
hr) was equivalent to that of ES cells (17.0 hr). We desig-nated these cells iPS-MEF24 for ‘‘pluripotent stem cells in-
duced from MEFs by 24 factors.’’ Reverse transcription
PCR (RT-PCR) analysis revealed that the iPS-MEF24
clones expressed ES cell markers, including Oct3/4,
Nanog, E-Ras, Cripto, Dax1, and Zfp296 (Mitsui et al.,
2003) and Fgf4 (Yuan et al., 1995) (Figure 1E). Bisulfite
genomic sequencing demonstrated that the promoters
of Fbx15 and Nanog were demethylated in iPS cells
(Figure 1F). By contrast, the Oct3/4 promoter remained
methylated in these cells. These data indicate that some
combination of these 24 candidate factors induced the
expression of ES cell marker genes in MEF culture.
Next, to determine which of the 24 candidates were crit-
ical, we examined the effect of withdrawal of individual
factors from the pool of transduced candidate genes on
the formation of G418-resistant colonies (Figure 2A). We
identified 10 factors (3, 4, 5, 11, 14, 15, 18, 20, 21, and
22) whose individual withdrawal from the bulk transduc-
tion pool resulted in no colony formation 10 days afterCell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc. 665
transduction and fewer colonies 16 days after transduc-
tion. Combination of these 10 genes alone produced
more ES cell-like colonies than transduction of all 24
genes did (Figure 2B).
We next examined the formation of colonies after with-
drawal of individual factors from the 10-factor pool trans-
duced into MEFs (Figure 2B). G418-resistant colonies did
not form when either Oct3/4 (factor 14) or Klf4 (factor 20)
was removed. Removal of Sox2 (factor 15) resulted in
only a few G418-resistant colonies. When we removed
c-Myc (factor 22), G418-resistant colonies did emerge,
but these had a flatter, non-ES-cell-like morphology. Re-
moval of the remaining factors did not significantly affect
colony numbers. These results indicate that Oct3/4, Klf4,
Sox2, and c-Myc play important roles in the generation
of iPS cells from MEFs.
Combination of the four genes produced a number of
G418-resistant colonies similar to that observed with the
pool of 10 genes (Figure 2C). We continued cultivation of
12 clones for each transduction and were able to establish
4 iPS-MEF4 and 5 iPS-MEF10 clones. In addition, we
could generate iPS cells (iPS-MEF4wt) with wild-type
c-Myc instead of the T58A mutant (Table S2). These data
demonstrate that iPS cells can be induced from MEF
culture by the introduction of four transcription factors,
Oct3/4, Sox2, c-Myc, and Klf4.
No combination of two factors could induce the forma-
tion of G418-resistant colonies (Figure 2C). Two combina-
tions of three factors—Oct3/4, Sox2, and c-Myc (minus
Klf4) or Klf4, Sox2, and c-Myc (minus Oct3/4)—generated
a single, small colony in each case, but these could not be
maintained in culture. With the combination of Oct3/4,
Klf4, and Sox2 (minus c-Myc), we observed the formation
of 36 G418-resistant colonies, which, however, exhibited
a flat, non-ES-cell-like morphology. With the combination
of Oct3/4, Klf4, and c-Myc (minus Sox2), we observed
the formation of 54 G418-resistant colonies, of which we
picked 6. Although all 6 clones could be maintained over
several passages, the morphology of these cells (iPS-
MEF3) differed from that of iPS-MEF4 and iPS-MEF10
cells, with iPS-MEF3 colonies exhibiting rough surfaces
(Figure 2D). These data indicate that the combination of
Oct3/4, c-Myc, and Klf4 can activate the Fbx15 locus,
but the change induced by these three factors alone is dif-
ferent from that seen in iPS-MEF4 or iPS-MEF10 cells.
We performed RT-PCR to examine whether ES cell
marker genes were expressed in iPS cells (Figure 3A).
We used primers that would amplify transcripts of the en-
dogenous gene but not transcripts of the transgene. iPS-
MEF10 and iPS-MEF4 clones expressed the majority of
marker genes, with the exception of Ecat1 (Mitsui et al.,
2003). The expression of several marker genes, including
Oct3/4, was higher in iPS-MEF4-7, iPS-MEF10-6, and
iPS-MEF10-7 clones than in the remaining clones. Sox2
was only expressed in iPS-MEF10-6. The iPS-MEF4wt
clone also expressed many of the ES cell marker genes
(Figure S1). Chromatin immunoprecipitation analyses
showed that the promoters of Oct3/4 and Nanog had666 Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc.increased acetylation of histone H3 and decreased
dimethylation of lysine 9 of histone H3 (Figure 3B). CpG
dinucleotides in these promoters remained partially
methylated in iPS cells (Figure 3C). iPS-MEF4 and iPS-
MEF10 cells were positive for alkaline phosphatase and
SSEA-1 (Figure 3D) and showed high telomerase activity
(Figure S2). These results demonstrate that iPS-MEF4
and iPS-MEF10 cells are similar, but not identical, to ES
cells.
In iPS-MEF3 clones, Ecat1, Esg1, and Sox2 were not
activated (Figure 3A). Nanog was induced, but to a lesser
extent than in iPS-MEF4 and iPS-MEF10 clones. Oct3/4
was weakly activated in iPS-MEF3-3, -5, and -6 but was
not activated in the remaining clones. By contrast, E-Ras
and Fgf4 were activated more efficiently in iPS-MEF3
than in iPS-MEF10 or iPS-MEF4. These data confirm
that iPS-MEF3 cells are substantially different from iPS-
MEF10 and iPS-MEF4 cells.
We compared the global gene-expression profiles of
ES cells, iPS cells, and Fbx15bgeo/bgeo MEFs using DNA
microarrays (Figure 4A). In addition, we examined
Fbx15bgeo/bgeo MEFs in which the four factors had been
introduced without G418 selection, immortalized MEFs
expressing K-RasV12, and NIH 3T3 cells transformed
with H-RasV12. Pearson correlation analysis revealed
that iPS cells are clustered closely with ES cells but sepa-
rately from fibroblasts and their derivatives (Figure 4A).
The microarray analyses identified genes that were com-
monly upregulated in ES cells and iPS cells, including
Myb, Kit, Gdf3, and Zic3 (group I, Figure 4B and Table
S3). Other genes were upregulated more efficiently in ES
cells, iPS-MEF4, and iPS-MEF10 than in iPS-MEF3
clones, including Dppa3, Dppa4, Dppa5, Nanog, Sox2,
Esrrb, and Rex1 (group II). Lower expression of these
genes may account for the lack of pluripotency in iPS-
MEF3 cells. In addition, we found genes that were upregu-
latedmore prominently in ES cells than in iPS cells, includ-
ing Dnmt3a, Dnmt3b, Dnmt3l, Utf1, Tcl1, and the LIF
receptor gene (group III). These data confirm that iPS cells
are similar, but not identical, to ES cells.
We examined the pluripotency of iPS cells by teratoma
formation (Figure 5A; Table S6 and Figure S3). We ob-
tained tumors with 5 iPS-MEF10 clones, 3 iPS-MEF4
clones, 1 iPS-MEF4wt clone, and 6 iPS-MEF3 clones
after subcutaneous injection into nude mice. Histological
examination revealed that 2 iPS-MEF10 clones (3 and 6),
2 iPS-MEF4 clones (2 and 7), and the iPS-MEF4wt-4 clone
differentiated into all three germ layers, including neural
tissues, cartilage, and columnar epithelium. iPS-MEF10-
6 could give rise to all three germ layers even after 30 pas-
sages (Table S6 and Figure S3). We confirmed differentia-
tion into neural and muscle tissues by immunostaining
(Figure 5B) and RT-PCR (Figure S4). By contrast, these
teratomas did not express the trophoblast marker Cdx2
(Figure S4). iPS-MEF10-1 tumors differentiated into ecto-
derm and endoderm, but not mesoderm, and no signs of
differentiation were observed in tumors derived from the
remaining iPS-MEF10 (7 and 10) or from iPS-MEF4-10.
Figure 3. Gene-Expression Profiles of iPS Cells
(A) RT-PCR analysis of ES marker genes in iPS cells, ES cells, and MEFs. We used primer sets that amplified endogenous but not transgenic
transcripts.
(B) The promoters ofOct3/4 andNanogwere analyzed by ChIP for dimethylation status of lysine 9 of histone H3 and acetylation status of histone H3 in
ES cells, MEFs, and iPS cells (MEF4-7 and MEF10-6). Data were quantified by real-time PCR. Shown are the averages and standard deviations of
relative values compared to ES cells (n = 3). *p < 0.05; **p < 0.01 compared to MEFs.
(C) The promoters of Oct3/4, Nanog, and Fbx15 were analyzed with bisulfite genomic sequencing for DNA methylation status in iPS-MEF4-7 and
iPS-MEF10-6. The DNA methylation status of these promoters in ES cells and MEFs is shown in Figure 1F.
(D) iPS-MEF4-7 and iPS-MEF10-6 clones were stained with a mouse monoclonal antibody against SSEA-1 (480, Santa Cruz) or with an alkaline
phosphatase kit (Sigma). Scale bars = 500 mm (SSEA1) and 1 mm (AP).These data demonstrate that the majority of, but not all,
iPS-MEF10 and iPS-MEF4 clones exhibit pluripotency.
In contrast, all tumors derived from iPS-MEF3 clones
were composed entirely of undifferentiated cells (Table
S6 and Figure S3). Thus, although the three factors
(Oct3/4, c-Myc, and Klf4) could induce the expression of
some ES cell marker genes, they were not able to induce
pluripotency.
iPS-MEF10, iPS-MEF4, and iPS-MEF3 cells formed em-
bryoid bodies in noncoated plastic dishes (Figure 5C).When grown in tissue culture dishes, the embryoid bodies
from iPS-MEF10 and iPS-MEF4 cells attached to the dish
bottom and initiated differentiation. After 3 days, immu-
nostaining detected cells positive fora-smoothmuscle ac-
tin (mesoderm marker), a-fetoprotein (endoderm marker),
and bIII tubulin (ectodermmarker) (Figure 5D). By contrast,
embryoid bodies from iPS-MEF3 cells remained undiffer-
entiated even when cultured in gelatin-coated dishes (Fig-
ure 5C). These data confirmed pluripotency of iPS-MEF10
and iPS-MEF4 and nullipotency of iPS-MEF3 in vitro.Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc. 667
Figure 4. Global Gene-Expression
Analyses by DNA Microarrays
(A) Pearson correlation analysis of 10,517
probes was performed to cluster ES cells,
iPS cells (MEF4- 7, MEF10-6, MEF3-2, and
MEF3-3), MEFs, MEFs expressing the four
factors, immortalized MEFs expressing
K-RasV12, and NIH 3T3 cells transformed
by H-RasV12. Red indicates increased
expression compared to median levels of
the eight samples, whereas green means
decreased expression.
(B) Genes upregulated in ES and/or iPS cells.
Genes in group I are genes upregulated in ES
cells and iPS cells. Genes in group II are
upregulated more in ES cells, iPS-MEF4-7,
and iPS-MEF10-6 than in iPS-MEF3 cells.
Genes in group III are upregulated more in
ES cells than in iPS cells. Lists of genes are
shown in Tables S3–S5.668 Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc.
Figure 5. Pluripotency of iPS Cells
Derived from MEFs
(A) Various tissues present in teratomas de-
rived from iPS-MEF4-7 cells. Histology of other
teratomas is shown in Figure S3 and Table S6.
(B) Immunostaining confirming differentiation
into neural tissues and muscles in teratomas
derived from iPS-MEF4-7.
(C) In vitro embryoid body formation (upper
row) and differentiation (lower row). Scale
bars = 200 mm.
(D) Immunostaining confirming in vitro differen-
tiation into all three germ layers. Scale bars =
100 mm. Secondary antibodies were labeled
with Cy3 (red), except for a-fetoprotein in iPS-
MEF10-6, with which Alexa 488 (green) was
used.We next introduced the four selected factors into tail-tip
fibroblasts (TTFs) of four 7-week-old male Fbx15bgeo/bgeo
mice on a C57/BL6-129 hybrid background. We obtained
3 G418-resistant colonies, from each of which we could
establish iPS cells (iPS-TTF4). We also introduced the
four factors into TTFs from a 12-week-old female
Fbx15bgeo/bgeo mouse, which also constitutively ex-
pressed green fluorescent protein (GFP) from the CAG
promoter and had a C57/BL6-129-ICR hybrid back-
ground. Of the 13 G418-resistant colonies obtained, we
isolated 6 clones from which we could establish iPS cells(iPS-TTFgfp4, clones 1–6). In addition, we established
another iPS-TTFgfp4 (clone 7), in which the cDNA for
each of the four factors was flanked with two loxP sites
in the transgene. These cells were morphologically indis-
tinguishable from ES cells (Figure 6A). RT-PCR showed
that clones 3 and 7 of iPS-TTFgfp4 expressed the majority
of ES cell marker genes at high levels and the others at
lower levels (Figure 6B). In another attempt, we used either
the T58A mutant or the wild-type c-Myc for transduction
and established 5 iPS-TTFgfp4 clones (clones 8–12) and
3 iPS-TTFgfp4wt clones (clones 1–3) (Figure S5). RT-PCRCell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc. 669
Figure 6. Characterization of iPS Cells Derived from Adult Mouse Tail-Tip Fibroblasts
(A) Morphology of iPS-TTFgfp4-3 on STO feeder cells.
(B) RT-PCR analysis of ES marker gene expression in iPS-TTFgfp4 cells (clones 1–5 and 7). We used primer sets that amplified endogenous but not
transgenic transcripts.
(C) Contribution of iPS-TTFgfp4-7 and iPS-TTFgfp4-3 cells tomouse embryonic development. iPS cells weremicroinjected into C57/BL6 blastocysts.
Embryos were analyzed with a fluorescence microscope at E7.5 (upper panels, iPS-TTFgfp4-7) or E13.5 (lower panels, iPS-TTFgfp4-3). Scale bars =
200 mm (upper panels) and 2 mm (lower panels).
(D) The E13.5 chimeric embryo was sectioned and stained with anti-GFP antibody (brown). Cells were counterstained with eosin (blue).showed that iPS-TTFgfp4wt cells also expressed most
of the ES cell marker genes (Figure S6).
We transplanted 2 iPS-TTF4 and 6 iPS-TTFgfp4 clones
into nude mice, all of which produced tumors containing
tissues of all three germ layers (Table S6 and Figure S3).
We then introduced 2 clones of iPS-TTFgfp4 cells (clones
3 and 7) into C57/BL6 blastocysts by microinjection. With
iPS-TTFgfp4-3, we obtained 18 embryos at E13.5, 2 of
which showed contribution of GFP-positive iPS cells
(Figure 6C). Histological analyses confirmed that iPS cells670 Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc.contributed to all three germ layers (Figure 6D). We ob-
served GFP-positive cells in the gonad but could not de-
termine whether they were germ cells or somatic cells.
With iPS-TTFgfp4-7, we obtained 22 embryos at E7.5, 3
of which were positive for GFP. With the 2 clones, we
had 27 pups born, but none of them were chimeric mice.
In addition, iPS-TTFgfp4 cells could differentiate into all
three germ layers in vitro (Figure S7). These data demon-
strate that the four selected factors could induce pluripo-
tent cells from adult mouse fibroblast cultures.
We further characterized the expression of the four fac-
tors and others in iPS cells. Real-time PCR confirmed that
endogenous expression of Oct3/4 and Sox2 was lower in
iPS cells than in ES cells (Figure S8). However, the total
amount of the four factors from the endogenous genes
and the transgenes exceeded the normal expression
levels in ES cells. In contrast, Western blot analyses
showed that the total protein amounts of the four factors
in iPS cells were comparable to those in ES cells (Fig-
ure 7A; Figure S8).We could detect Nanog and E-Ras pro-
teins in iPS cells, but at lower levels than those in ES cells
(Figures 7A and 7B; Figure S8). The p53 levels in iPS cells
were lower than those in MEFs and equivalent to those in
ES cells (Figure 7A; Figure S9). The p21 levels in iPS cells
varied in each clone and were between those in ES cells
and MEFs (Figure S9). Upon differentiation in vitro, the to-
tal mRNA expression levels ofOct3/4 andSox2 decreased
but remained much higher than in ES cells. In contrast,
their protein levels decreased to comparable levels in
iPS cells and ES cells (Figure 7B).
Southern blot analyses showed that each iPS clone has
a unique transgene integration pattern (Figure 7C). Karyo-
typing analyses of the iPS-TTFgfp4 (clones 1, 2, 3, 7, and
11) and iPS-TTFgfp4wt (clones 1–3) demonstrated that 2
iPS-TTFgfp4 clones and all of the iPS-TTFgfp4wt clones
showed a normal karyotype of 40XX (Figure 7D), while
the other 3 iPS-TTFgfp4 clones were 39XO, 40XO +10,
and 40Xi(X). Analyses of PCR-based simple sequence
length polymorphisms (SSLPs) demonstrated that iPS-
MEF clones have a mixed background of C57/BL6 and
129 (Table S7), whereas iPS-TTFgfp clones have a mixed
background of ICR, C57/BL6, and 129 (Table S8). Finally,
we found that iPS cells could not remain undifferentiated
when cultured in the absence of feeder cells, even with
the presence of LIF (Figure 7E). These results, together
with the different gene-expression patterns, exclude the
possibility that iPS cells are merely contamination of pre-
existing ES cells. Finally, subclones of iPS cells were pos-
itive for alkaline phosphatase and could differentiate into
all three germ layers in vitro (Figure S10), confirming their
clonal nature.
DISCUSSION
Oct3/4, Sox2, and Nanog have been shown to function
as core transcription factors in maintaining pluripotency
(Boyer et al., 2005; Loh et al., 2006). Among the three,
we found that Oct3/4 and Sox2 are essential for the gen-
eration of iPS cells. Surprisingly, Nanog is dispensable. In
addition, we identified c-Myc and Klf4 as essential factors.
These two tumor-related factors could not be replaced by
other oncogenes including E-Ras, Tcl1, b-catenin, and
Stat3 (Figures 2A and 2B).
The c-Myc protein has many downstream targets that
enhance proliferation and transformation (Adhikary and
Eilers, 2005), many of which may have roles in the gener-
ation of iPS cells. Of note, c-Myc associates with histoneacetyltransferase (HAT) complexes, including TRRAP,
which is a core subunit of the TIP60 and GCN5 HAT com-
plexes (McMahon et al., 1998), CREB binding protein
(CBP), and p300 (Vervoorts et al., 2003). Within the mam-
malian genome, there may be up to 25,000 c-Myc binding
sites (Cawley et al., 2004), many more than the predicted
number of Oct3/4 and Sox2 binding sites (Boyer et al.,
2005; Loh et al., 2006). c-Myc protein may induce global
histone acetylation (Fernandez et al., 2003), thus allowing
Oct3/4 and Sox2 to bind to their specific target loci.
Klf4 has been shown to repress p53 directly (Rowland
et al., 2005), and p53 protein has been shown to suppress
Nanog during ES cell differentiation (Lin et al., 2004). We
found that iPS cells showed levels of p53 protein lower
than those in MEFs (Figure 7A). Thus, Klf4 might contrib-
ute to activation ofNanog and other ES cell-specific genes
through p53 repression. Alternatively, Klf4 might function
as an inhibitor of Myc-induced apoptosis through the re-
pression of p53 in our system (Zindy et al., 1998). On the
other hand, Klf4 activates p21CIP1, thereby suppressing
cell proliferation (Zhang et al., 2000). This antiproliferation
function of Klf4 might be inhibited by c-Myc, which sup-
presses the expression of p21CIP1 (Seoane et al., 2002).
The balance between c-Myc and Klf4 may be important
for the generation of iPS cells.
One question that remains concerns the origin of our
iPS cells. With our retroviral expression system, we esti-
mated that only a small portion of cells expressing the
four factors became iPS cells (Figure S11). The low fre-
quency suggests that rare tissue stem/progenitor cells
that coexisted in the fibroblast cultures might have given
rise to the iPS cells. Indeed, multipotent stem cells have
been isolated from skin (Dyce et al., 2004; Toma et al.,
2001, 2005). These studies showed that 0.067% of
mouse skin cells are stem cells. One explanation for the
low frequency of iPS cell derivation is that the four factors
transform tissue stem cells. However, we found that the
four factors induced iPS cells with comparably low effi-
ciency even from bone marrow stroma, which should be
more enriched inmesenchymal stem cells and othermulti-
potent cells (Tables S2 and S6). Furthermore, cells in-
duced by the three factors were nullipotent (Table S6
and Figure S3). DNA microarray analyses suggested that
iPS-MEF4 cells and iPS-MEF3 cells have the same origin
(Figure 4). These results do not favor multipotent tissue
stem cells as the origin of iPS cells.
There are several other possibilities for the low fre-
quency of iPS cell derivation. First, the levels of the four
factors required for generation of pluripotent cells may
have narrow ranges, and only a small portion of cells ex-
pressing all four of the factors at the right levels can acquire
ES cell-like properties. Consistent with this idea, a mere
50% increase or decrease in Oct3/4 proteins induces
differentiation of ES cells (Niwa et al., 2000). iPS clones
overexpressed the four factors when RNA levels were an-
alyzed, but their protein levels were comparable to those in
EScells (Figures 7Aand7B; FigureS8), suggesting that the
iPS clones possess a mechanism (or mechanisms) thatCell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc. 671
Figure 7. Biochemical and Genetic Analyses of iPS Cells
(A) Western blot analyses of the four factors and other proteins in iPS cells (MEF4-7, MEF10-6, TTFgfp4-3, and TTFgfp4-7), ES cells, and MEFs.
(B) Changes in RNA (left) and protein (right) levels of Oct3/4, Sox2, and Nanog in iPS cells and ES cells that were undifferentiated on STO feeder cells
(U) or induced to differentiated in vitro through embryoid body formation (D). Shown are relative expression levels compared to undifferentiated ES
cells. Data of MEFs and TTFs are also shown. RNA levels were determined with real-time PCR using primers specific for endogenous transcripts672 Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc.
tightly regulates the protein levels of the four factors. We
speculate that high amounts of the four factors are re-
quired in the initial stage of iPS cell generation, but, once
they acquire ES cell-like status, too much of the factors
are detrimental for self-renewal. Only a small portion of
transduced cells show such appropriate transgene ex-
pression. Second, generation of pluripotent cells may
require additional chromosomal alterations, which take
place spontaneously during culture or are induced by
some of the four factors. Although the iPS-TTFgfp4 clones
had largely normal karyotypes (Figure 7D), we cannot rule
out the existence of minor chromosomal alterations. Site-
specific retroviral insertion may also play a role. Southern
blot analyses showed that each iPSclone has20 retroviral
integrations (Figure 7C). Some of these may have caused
silencingor fusionwith endogenousgenes. Further studies
will be required to determine the origin of iPS cells.
Another unsolved question is whether the four factors
we identified play roles in reprogramming induced by fu-
sion with ES cells or nuclear transfer into oocytes. Since
the four factors are expressed in ES cells at high levels,
it is reasonable to speculate that they are involved in the
reprogramming machinery that exists in ES cells. Our re-
sult is also consistent with the finding that the reprogram-
ming activity resides in the nucleus, but not in the cyto-
plasm, of ES cells (Do and Scholer, 2004). However, iPS
cells were not identical to ES cells, as shown by the global
gene-expression patterns and DNA methylation status. It
is possible that we have missed additional important fac-
tors. One such candidate is ECAT1, although its forced
expression in iPS cells did not consistently upregulate
ES cell marker genes (Figure S12).
More obscure are the roles of the four factors, especially
Klf4 and c-Myc, in the reprogramming observed in oo-
cytes. Both Klf4 and c-Myc are dispensable for preimplan-
tation mouse development (Baudino et al., 2002; Katz
et al., 2002). Furthermore, c-myc is not detected in oo-
cytes (Domashenko et al., 1997). In contrast, L-myc is ex-
pressedmaternally in oocytes.Klf17 andKlf7, but notKlf4,
are found in expressed sequence-tag libraries derived
from unfertilized mouse eggs. Klf4 and c-Myc might be
compensated by these related proteins. It is highly likely
that other factors are also required to induce complete
reprogramming and totipotency in oocytes.
It is likely that the four factors from the transgenes are
required for maintaining the iPS cells since the expression
of Oct3/4 and Sox2 from the endogenous genes remained
low (Figure 7B; Figure S8). We intended to prove this by
using transgenes flanked by two loxP sites and obtained
an iPS clone (TTF4gfp4-7). However, we noticed thatthese cells contain multiple loxP sites onmultiple chromo-
somes, and, thus, the Cre-mediated recombination would
cause not only deletion of the transgenes but also inter-
and intrachromosomal rearrangements. Studies with
conditional expression systems, such as the tetracycline-
mediated system, are required to answer this question.
We showed that the iPS cells can differentiate in vitro
and in vivo even with the presence of the retroviral vectors
containing the four factors. We found that Oct3/4 and
Sox2 proteins decreased significantly during in vitro differ-
entiation (Figure 7B). Retroviral expression has been
shown to be suppressed in ES cells and further silenced
upon differentiation by epigenetic modifications, such as
DNAmethylation (Yao et al., 2004). The samemechanisms
are likely to play roles in transgene repression in iPS cells
since they express Dnmt3a, 3b, and 3l, albeit at lower
levels than ES cells do (Table S5). In addition, we found
that iPS cells possess a mechanism (or mechanisms)
that lowers protein levels of the transgenes and Nanog
(Figure 7B; Figure S8). The same mechanism may be
enhanced during differentiation. However, silencing of
Oct3/4 in iPS-TTFgfp4-3 cells was not complete, which
may explain our inability to obtain live chimeric mice after
blastocyst microinjection of iPS cells.
An unexpected finding in this study was the efficient ac-
tivation of Fgf4 and Fbx15 by the combination of the three
factors devoid of Sox2 since these two genes have been
shown to be regulated synergistically by Oct3/4 and
Sox2 (Tokuzawa et al., 2003; Yuan et al., 1995). It is also
surprising that Nanog is dispensable for induction and
maintenance of iPS cells. More detailed analyses of iPS
cells will enhance our understanding of transcriptional
regulation in pluripotent stem cells.
Our findings may have wider applications, as we have
found that transgene reporters with other ES cell marker
genes, such asNanog, can replace the Fbx15 knockin dur-
ing selection (K. Okita and S.Y., unpublished data). How-
ever, we still do not knowwhether the four factors can gen-
erate pluripotent cells from human somatic cells. Use of
c-Myc may not be suitable for clinical applications, and
the process may require specific culture environments.
Nevertheless, the finding is an important step in controlling
pluripotency, which may eventually allow the creation of
pluripotent cells directly from somatic cells of patients.
EXPERIMENTAL PROCEDURES
Mice
Fbx15bgeo/bgeo mice were generated with 129SvJae-derived RF8 ES
cells as described previously (Tokuzawa et al., 2003) and were(white columns) or those common for both endogenous and transgenic transcripts (white and black columns). RNA expression levels are shown on
logarithmic axes. Protein levels were determined by Western blot normalized with b-actin. Protein levels are shown as the averages and standard
deviations on linear axes (n = 4). *p < 0.05 compared to undifferentiated cells.
(C) Southern blot analyses showing the integration of transgenes. Genomic DNA isolated from iPS cells and ES cells was digested with EcoRI and
BamHI, separated on agarose gel, transferred to a nylon membrane, and hybridized with a Klf4 cDNA probe.
(D) Normal karyotype of iPS-TTFgfp4-2 clone.
(E) Morphology of ES cells and iPS cells cultured without feeder cells. One thousand cells were cultured on gelatin-coated six-well plates for 5 days,
with or without LIF. Scale bars = 200 mm.Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc. 673
backcrossed to the C57/BL6 strain for at least five generations. These
micewere used for primarymouse embryonic fibroblast (MEF) and tail-
tip fibroblast (TTF) preparations. To generate Fbx15bgeo/bgeo mice with
constitutive expression of GFP, an Fbx15bgeo/bgeo mouse (C57/BL6-
129 background) was mated with an ICR mouse with the GFP trans-
gene driven by the constitutive CAG promoter (Niwa et al., 1991).
The resulting Fbx15bgeo/+,GFP/+ mice were intercrossed to generate
Fbx15bgeo/bgeo,GFP/GFP mice. Nude mice (BALB/Jcl-nu) were pur-
chased from CLEA.
Cell Culture
RF8 ES cells and iPS cells weremaintained on feeder layers of mitomy-
cin C-treated STO cells as previously described (Meiner et al., 1996).
As a source of leukemia inhibitory factor (LIF), we used conditioned
medium (1:10,000 dilution) from Plat-E cell cultures that had been
transduced with a LIF-encoding vector. ES and iPS cells were pas-
saged every 3 days. Plat-E packaging cells (Morita et al., 2000), which
were also used to produce retroviruses, were maintained in DMEM
containing 10% FBS, 50 units/50 mg/ml penicillin/streptomycin,
1 mg/ml puromycin (Sigma), and 100 mg/ml of blasticidin S (Funakoshi).
For MEF isolation, uteri isolated from 13.5-day-pregnant mice were
washed with phosphate-buffered saline (PBS). The head and visceral
tissues were removed from isolated embryos. The remaining bodies
were washed in fresh PBS, minced using a pair of scissors, transferred
into a 0.1 mM trypsin/1 mM EDTA solution (3 ml per embryo), and
incubated at 37C for 20 min. After incubation, an additional 3 ml per
embryo of 0.1 mM trypsin/1 mM EDTA solution was added, and the
mixture was incubated at 37C for 20min. After trypsinization, an equal
amount of medium (6 ml per embryo DMEM containing 10% FBS) was
added and pipetted up and down a few times to help with tissue dis-
sociation. After incubation of the tissue/medium mixture for 5 min at
room temperature, the supernatant was transferred into a new tube.
Cells were collected by centrifugation (200 3 g for 5 min at 4C) and
resuspended in fresh medium. 13 106 cells (passage 1) were cultured
on 100 mm dishes at 37C with 5% CO2. In this study, we used MEFs
within three passages to avoid replicative senescence.
To establish TTFs, the tails from adult mice were peeled, minced into
1 cm pieces, placed on culture dishes, and incubated in MF-start me-
dium (Toyobo) for 5 days. Cells that migrated out of the graft pieces
were transferred to new plates (passage 2) and maintained in DMEM
containing 10%FBS.We used TTFs at passage 3 for iPS cell induction.
Retroviral Infection
The day before transduction, Plat-E cells (Morita et al., 2000) were
seeded at 83 106 cells per 100mmdish.On the next day, pMXs-based
retroviral vectors were introduced into Plat-E cells using Fugene 6
transfection reagent (Roche) according to the manufacturer’s recom-
mendations. Twenty-seven microliters of Fugene 6 transfection re-
agent was diluted in 300 ml DMEMand incubated for 5min at room tem-
perature. Nine micrograms of plasmid DNA was added to the mixture,
which was incubated for another 15 min at room temperature. After in-
cubation, the DNA/Fugene 6 mixture was added drop by drop onto
Plat-E cells. Cells were then incubated overnight at 37Cwith 5%CO2.
Twenty-four hours after transduction, the medium was replaced.
MEFs or TTFs were seeded at 83 105 cells per 100 mm dish on mito-
mycin C-treated STO feeders. After 24 hr, virus-containing superna-
tants derived from these Plat-E cultures were filtered through a
0.45 mm cellulose acetate filter (Schleicher & Schuell) and supple-
mented with 4 mg/ml polybrene (Nacalai Tesque). Target cells were in-
cubated in the virus/polybrene-containing supernatants for 4 hr to
overnight. After infection, the cells were replated in 10 ml fresh
medium. Three days after infection, we added G418 at a final concen-
tration of 0.3 mg/ml. Clones were selected for 2 to 3 weeks.
Plasmid Construction
To generate pMXs-gw, we introduced a Gateway cassette rfA (Invitro-
gen) into the EcoRI/XhoI site of the pMXs plasmid. Primers used are674 Cell 126, 663–676, August 25, 2006 ª2006 Elsevier Inc.listed in Table S9. Mutations in b-catenin, c-myc, and Stat3were intro-
duced by PCR-based site-directed mutagenesis. For forced expres-
sion, we amplified the coding regions of candidate genes by RT-PCR,
cloned these sequences into pDONR201 or pENTR-D-TOPO (Invitro-
gen), and recombined the resulting plasmids with pMXs-gw by LR
reaction (Invitrogen).
Teratoma Formation and Histological Analysis
ES cells or iPS cells were suspended at 13 107 cells/ml in DMEM con-
taining 10% FBS. Nude mice were anesthetized with diethyl ether. We
injected 100 ml of the cell suspension (1 3 106 cells) subcutaneously
into the dorsal flank. Four weeks after the injection, tumors were surgi-
cally dissected from the mice. Samples were weighed, fixed in PBS
containing 4% formaldehyde, and embedded in paraffin. Sections
were stained with hematoxylin and eosin.
Bisulfite Genomic Sequencing
Bisulfite treatment was performed using the CpGenome modification
kit (Chemicon) according to the manufacturer’s recommendations.
PCR primers are listed in Table S9. Amplified products were cloned
intopCR2.1-TOPO (Invitrogen). Ten randomly selectedcloneswere se-
quencedwith theM13 forward andM13 reverse primers for each gene.
Determination of Karyotypes and SSLP by PCR
Karyotypes were determined with quinacrine-Hoechst staining at the
International Council for Laboratory Animal Science (ICLAS) Monitor-
ing Center (Japan). We obtained PCR primer sequences for SSLP
from the Mouse Genome Informatics website (The Jackson Labora-
tory, http://www.informatics.jax.org). Allele sizes were approximated
on the basis of the known allele sizes in various inbred strains.
Western Blot Analyses
Western blot was performed as previously described (Takahashi et al.,
2003). The primary antibodies used were anti-Oct3/4 monoclonal
antibody (C-10, Santa Cruz), anti-Sox2 antiserum (Maruyama et al.,
2005), anti-Klf4 polyclonal antibody (H-180, Santa Cruz), anti-c-Myc
polyclonal antibody (A-14, Santa Cruz), anti-Nanog antiserum (Mitsui
et al., 2003), anti-E-Ras antiserum (Takahashi et al., 2003), anti-p53
polyclonal antibody (FL-393, Santa Cruz), and anti-b-actin monoclonal
antibody (A5441, Sigma).
RT-PCR for Marker Genes
We performed reverse transcription reactions using ReverTra Ace -a-
(Toyobo) and the oligo dT20 primer. PCR was done with ExTaq
(Takara). Real-time PCR was performed with Platinum SYBR Green
qPCR SuperMix-UDG with ROX (Invitrogen) according to manufac-
turer’s instructions. Signals were detected with an ABI7300 Real-
Time PCR System (Applied Biosystems). Primer sequences are listed
in Table S9.
DNA Microarray
Total RNA from ES cells, iPS cells, or MEFs were labeled with Cy3.
Samples were hybridized to a Mouse Oligo Microarray (G4121B, Agi-
lent) according to the manufacturer’s protocol. Arrays were scanned
with a G2565BA Microarray Scanner System (Agilent). Data were ana-
lyzed using GeneSpring GX software (Agilent).
In Vitro Differentiation of iPS Cells
Cells were harvested by trypsinization and transferred to bacterial cul-
ture dishes in the ESmediumwithout G418 or LIF. After 3 days, aggre-
gated cells were plated onto gelatin-coated tissue culture dishes and
incubated for another 3 days. The cells were stained with anti-
a-smooth muscle actin monoclonal antibody (N1584, Dako), anti-a-
fetoprotein polyclonal antibody (N1501, Dako) or anti-bIII tubulin
monoclonal antibody (CBL412, Abcam) along with 40-6-diamidino-
2-phenylindole (Sigma). Total RNA derived from plated embryoid
bodies on day 6 was used for RT-PCR analysis.
Chromatin Immunoprecipitation Assay
We performed chromatin immunoprecipitation (ChIP) as previously
described (Maruyama et al., 2005). Antibodies used in this experiment
were anti-dimethyl K9 H3 rabbit polyclonal antibody (ab7312-100,
Abcam) and anti-acetyl H3 rabbit polyclonal antibody (06-599,
Upstate). PCR primers are listed in Table S9.
Statistical Analyses
Data are shown as averages and standard deviations. We used
Student’s t test for protein-level analyses and one-factor ANOVA
with Scheffe’s post hoc test for ChIP analyses. All statistical analyses
were done with Excel 2003 (Microsoft) with the Statcel2 add-on (OMS).
Supplemental Data
Supplemental Data include 12 figures and 9 tables and can be found
with this article online at http://www.cell.com/cgi/content/full/126/4/
663/DC1/.
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